Inmunotherapy

To investigate new immunotherapeutic approaches: check-point inhibitors, Chimeric Antigenic Receptor T-cells (CAR-T), B-cell Antigenic Receptor T-cells (BAR-T), etc
To develop new therapeutic interventions
To evaluate new inmunotherapies
To create a Cellular Therapy Banking